Brendan Hannah insider trades

Open-market stock purchases and sales by Brendan Hannah, CBO, COO & CCO at Quince Therapeutics, Inc, from SEC Form 4 filings since May 19, 2022.

Track record: 86% of 7 scored buys are up 5% or more since purchase, averaging +53%.

Recent trades

DateStockTradeValue
Jan 23, 2026QNCX Quince Therapeutics, IncSold (not open market)—
Dec 5, 2025QNCX Quince Therapeutics, IncBought (not open market)—
Dec 5, 2025QNCX Quince Therapeutics, IncBought (not open market)—

Companies traded

  • QNCX Quince Therapeutics, Inc: 7 buys, last Jan 23, 2026
  • CRTX Cortexyme, Inc: other filings, last May 23, 2022

Get free alerts when Brendan Hannah files a new trade →